Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Which Medication Will Win
Potential therapeutic approaches have included activating or prolonging activation of the insulin receptor, promoting signalling through post-receptor pathways and increasing the activity of biological effectors
, ,
A brand-new category, QA0 , captures: Neurodevelopmental disorders related to pathogenic variants in specific genes (QA0.01-) Other neurodevelopmental disorders related to pathogenic variants (QA0.8) Additionally, 23 new codes add granularity for syndromes including Hao-Fountain Syndrome, CTNNB1 Syndrome, Kabuki Syndrome, and Usher Syndrome (now coded by type)
US$ 20.16
US$ 20.51
US$ 21.38
US$ 20.10
US$ 23.97
US$ 26.00
US$ 25.16
